Search
Add Trial
Sign In

A Phase III Prospective Double Blind Placebo Controlled Randomized Study of Adjuvant MEDI4736 In Completely Resected Non-Small Cell Lung Cancer

 

Study Type Treatment
Sponsor Name Astrazeneca
Disease type Non-Small Cell Lung Cancer
Disease Stage IB – IIIA
Clinical Status Adjuvant
Phase III
Intervention / Treatment Durvalumab versus Placebo
Research Site Montreal University Hospital Center
Investigator Dr Moishe Liberman
Coordinator Vicky Thiffault
Telephone number
Fax number
Study start date October 9, 2014
Study end date
Trial Status Recruiting
Study Type Treatment, Interventional
Sponsor Name
Tumor Site NSCLC - Non Small Cell Lung Cancer
Disease Stage Stage I, Stage II, Stage III
Clinical Status Adjuvant, Operable
Phase Phase I
Intervention / Treatment
Research Site Montreal, QC, Montreal University Hospital Center
Investigator
Coordinator
Telephone Number +1 (514) 890-8000
Fax Number
Study Start Date
Study End Date
Trial Status

Tags

Working Hours :

Now Closed UTC - 4
  • MondayDay Off
  • TuesdayDay Off
  • WednesdayDay Off
  • ThursdayDay Off
  • FridayDay Off
  • SaturdayDay Off
  • SundayDay Off

Price / Claim :

Recruit a patient:

*for confidentiality, do not include the name of the patient

*pour raisons de confidentialité, n'incluez pas le nom du patient

Hosted by :

Claim listing: CCTG BR.31

Our website is under development. We're sorry for any inconvenience that might appear.Notre site web est en cours de développement. Nous sommes désolés pour tout inconvénient qui pourrait survenir.

Reply to Message

Sign In KANCEL

Account details will be confirmed via email.

Reset Your Password